click to expand
The identification of new therapeutic targets is urgently
needed due to the ineffectiveness of current targets
Researchers from IMIM (Hospital del Mar Medical Research
Institute) have identified a new protein, galectin-1, as a possible therapeutic
target for pancreatic cancer. For the first time they have demonstrated the
effects of the inhibition of this protein in mice suffering this type of cancer
and the results showed an increase in survival of 20%. The work further
suggests that it could be a therapeutic target with no adverse effects.